Cytogenetic Investigations in Mentally Retarded and Normal Males from 14 Families with the Fragile Site at Xq28. Results of Folic Acid Treatment on Fra(X) Expression

Overview

Journal Hum Genet

Specialty Genetics

Date 1984 Jan 1

PMID 6232199

Citations 3

Authors

K B NIELSEN

N Tommerup

Affiliations

Soon will be listed here.

Abstract

Lymphocyte cultures from 27 mentally retarded males aged 1 year to 77 years, and from 11 normal brothers from a total of 14 families with the fragile X segregating have been examined cytogenetically employing three different culture methods including methods for induction of fra(X) by FUdR (flourodeoxyuridine) or MTX (methotrexate). All mentally retarded males showed unequivocal fra(X) expression. No statistically significant correlation between fra(X) expression and age could be demonstrated. No enhancement with FUdR was observed. Fibroblast cultures from 10 retarded males expressed fra(X) in a dose-response relationship to increasing concentrations of FUdR. None of the normal males showed fra(X). In vivo folic acid treatment of seven mentally retarded males resulted in marked reduction in fra(X) expression in lymphocyte cultures grown in medium 199. However, reinduction was achieved by FUdR or MTX, except in one case who temporarily received very high doses of folic acid.

Citing Articles

A set of male monozygotic triplets with schizophrenic psychoses: nature or nurture?.

Harnryd C, Jonsson E, Greitz D, Nyman H, Sedvall G Eur Arch Psychiatry Clin Neurosci. 1995; 245(1):1-7.

PMID: 7786906 DOI: 10.1007/BF02191537.

The role of fluorinated pyrimidine analogues in the induction of the in vitro expression of the fragile X chromosome.

Vandamme B, Liebaers I, Hens L, Bernheim J, Roobol C Hum Genet. 1988; 79(4):341-6.

PMID: 2970425 DOI: 10.1007/BF00282173.

The fragile X mutation does not have any major effect on the expression of the hypoxanthine phosphoribosyltransferase (HPRT) locus in human fibroblasts.

Steen A, MARCUS S, Sahlen S, NIELSEN K, Lambert B Hum Genet. 1991; 87(4):503-5.

PMID: 1715310 DOI: 10.1007/BF00197177.

References

Brookwell R, Daniel A, Turner G, Fishburn J . The fragile X(q27) form of X-linked mental retardation: FUdR as an inducing agent for fra(X)(q27) expression in lymphocytes, fibroblasts, and amniocytes. Am J Med Genet. 1982; 13(2):139-48. DOI: 10.1002/ajmg.1320130206. View

Turner G, Daniel A, Frost M . X-linked mental retardation, macro-orchidism, and the Xq27 fragile site. J Pediatr. 1980; 96(5):837-41. DOI: 10.1016/s0022-3476(80)80552-x. View

Nielsen L, NIELSEN K, Tommerup N . Fragile X demonstrated retrospectively in amniotic cells cultured in low folate medium. Prenat Diagn. 1983; 3(4):367-9. DOI: 10.1002/pd.1970030417. View

NIELSEN K, Tommerup N, POULSEN H, Jacobsen P, Beck B, Mikkelsen M . Carrier detection and X-inactivation studies in the fragile X syndrome. Cytogenetic studies in 63 obligate and potential carriers of the fragile X. Hum Genet. 1983; 64(3):240-5. DOI: 10.1007/BF00279401. View

Sherman S, Morton N, Jacobs P, Turner G . The marker (X) syndrome: a cytogenetic and genetic analysis. Ann Hum Genet. 1984; 48(1):21-37. DOI: 10.1111/j.1469-1809.1984.tb00830.x. View

Glover T . FUdR induction of the X chromosome fragile site: evidence for the mechanism of folic acid and thymidine inhibition. Am J Hum Genet. 1981; 33(2):234-42. PMC: 1684940. View

Mattei M, Mattei J, Vidal I, Giraud F . Expression in lymphocyte and fibroblast culture of the fragile X chromosome: a new technical approach. Hum Genet. 1981; 59(2):166-9. DOI: 10.1007/BF00293069. View

. Marker X syndrome. Am J Med Genet. 1983; 14(2):407-8. DOI: 10.1002/ajmg.1320140226. View

Webb T, Gosden C, Rodeck C, Hamill M, Eason P . Prenatal diagnosis of X-linked mental retardation with fragile (X) using fetoscopy and fetal blood sampling. Prenat Diagn. 1983; 3(2):131-7. DOI: 10.1002/pd.1970030210. View

10.

Fishburn J, Turner G, Daniel A, Brookwell R . The diagnosis and frequency of X-linked conditions in a cohort of moderately retarded males with affected brothers. Am J Med Genet. 1983; 14(4):713-24. DOI: 10.1002/ajmg.1320140413. View

11.

Webb G, Rogers J, PITT D, Halliday J, Theobald T . Transmission of fragile (X) (q27) site from a male. Lancet. 1981; 2(8257):1231-2. DOI: 10.1016/s0140-6736(81)91470-7. View

12.

Renier W, Smeets D, Scheres J, HUSTINX T, Hulsmans C, Ophey C . The Martin-Bell syndrome: a psychological, logopaedic and cytogenetic study of two affected brothers. J Ment Defic Res. 1983; 27 (Pt 1):51-9. DOI: 10.1111/j.1365-2788.1983.tb00163.x. View

13.

McDermott A, Walters R, Howell R, Gardner A . Fragile X chromosome: clinical and cytogenetic studies on cases from seven families. J Med Genet. 1983; 20(3):169-78. PMC: 1049041. DOI: 10.1136/jmg.20.3.169. View

14.

Mattei J, Mattei M, Aumeras C, Auger M, Giraud F . X-linked mental retardation with the fragile X. A study of 15 families. Hum Genet. 1981; 59(4):281-9. DOI: 10.1007/BF00295459. View

15.

Reyes P, HEIDELBERGER C . Fluorinated pyrimidines. XXVI. Mammalian thymidylate synthetase: its mechanism of action and inhibition by fluorinated nucleotides. Mol Pharmacol. 1965; 1(1):14-30. View

16.

Daker M, Chidiac P, Fear C, Berry A . Fragile X in a normal male: a cautionary tale. Lancet. 1981; 1(8223):780. DOI: 10.1016/s0140-6736(81)92652-0. View

17.

Schmidt A . Fragile site Xq27 and mental retardation. Clinical and cytogenetic manifestation in heterozygotes and hemizygotes of five kindreds. Hum Genet. 1982; 60(4):322-7. DOI: 10.1007/BF00569212. View

18.

Yunis J . High resolution of human chromosomes. Science. 1976; 191(4233):1268-70. DOI: 10.1126/science.1257746. View

19.

Jacky P, Dill F . Expression in fibroblast culture of the satellited-X chromosome associated with familial sex-linked mental retardation. Hum Genet. 1980; 53(2):267-9. DOI: 10.1007/BF00273509. View

20.

Tommerup N, POULSEN H, Brondum-Nielsen K . 5-Fluoro-2'-deoxyuridine induction of the fragile site on Xq28 associated with X linked mental retardation. J Med Genet. 1981; 18(5):374-6. PMC: 1048760. DOI: 10.1136/jmg.18.5.374. View